Earlier diagnostic options for MS are now possible, Zyn nicotine pouches get an FDA risk claim, and norovirus concerns rise.
TG Therapeutics recently initiated an open-label Phase 2 trial of BRIUMVI (ublituximab-xiiy) in about 60 adults with ...
The collaboration will bring Cortechs.ai's quantitative MRI analysis into Viz.ai's care coordination platform, beginning with ...
The partnership brings quantitative MRI into real-time clinical workflows, helping neurologists track disease progression and ...
A to Z Sports on MSN
Chris Johnson's ALS diagnosis sparks Ice Bucket Challenge revival, but expert says awareness alone won't move the needle
ALS is a hot topic this summer in the wake of Chris Johnson's diagnosis. But what can be done besides the revival of the Ice ...
A new study uses generative AI and MMCLE to reveal invisible gray matter cortical lesions on legacy MS MRI scans.
TG Therapeutics, Inc. (NASDAQ: TGTX) today announced the initiation of a Phase 2 clinical trial evaluating BRIUMVI® (ublituximab-xiiy), in adults with treatment-resistant schizophrenia. The Phase 2 ...
The Health Minister has expressed confidence in Irish maternity care after a former leading consultant criticised guidelines.
Abstract: This paper presents a novel low-cost and fully-portable instrumented shoe system for gait phase detection. The instrumented shoe consists of 174 independent sensing units constructed based ...
I was diagnosed with relapsing-remitting multiple sclerosis (RRMS) at the age of 46.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results